Literature DB >> 17477815

Polymorphisms in proinflammatory genes and susceptibility to typhoid fever and paratyphoid fever.

Soegianto Ali1, Albert M Vollaard, Dennis Kremer, Adriëtte W de Visser, Cerithsa A E Martina, Suwandhi Widjaja, Charles Surjadi, Eline Slagboom, Esther van de Vosse, Jaap T van Dissel.   

Abstract

Host genetic factors are thought to contribute to susceptibility and outcome in infectious diseases. A polymorphism in a proinflammatory gene, tumor necrosis factor-alpha (TNFA - 308), was recently found to be associated with susceptibility to typhoid fever. As the observation was made in hospitalized patients, a potential confounder could be that the TNFA polymorphism is associated with the severity of established illness resulting in hospital admission rather than susceptibility to disease. We tested whether the association with TNFA - 308 is present also in typhoid fever patients enrolled in a community-based case-control study in an endemic area in Indonesia. Common polymorphisms in other proinflammatory genes were assayed as well. Samples of patients with blood culture-confirmed typhoid fever (n = 90) and paratyphoid fever (n = 26) and fever controls (n = 337) were compared with those of community controls (n = 322). In these groups, we analyzed polymorphisms in TNFA by PCR and RFLP, polymorphisms of IFNG, IL1A, IL1B, IL1R1, TNFRSF1A, CASP1, and CRP by Sequenom MassArray (San Diego, CA), and polymorphisms in IL12B and IFNGR1 by fragment length analysis. The IL1R1 polymorphisms were nearly absent in the Indonesian population. The TNFA - 308 polymorphism was not associated with typhoid fever (OR 0.35, 95% CI 0.1-1.0) in this population. The polymorphisms at TNFA - 238 or in IFNG, IL1A, IL1B, IL12B, TNFRSF1A, IFNGR1, CASP1, and CRP were also not associated with typhoid or paratyphoid fever. We conclude that polymorphisms in proinflammatory genes do not contribute to susceptibility to typhoid fever and, in view of earlier findings, suggest that the TNFA - 308 polymorphism is likely related to severity of established disease rather than to susceptibility per se.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17477815     DOI: 10.1089/jir.2006.0129

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  7 in total

Review 1.  Genetics of susceptibility to infection with enteric pathogens.

Authors:  Jose Flores; Pablo C Okhuysen
Journal:  Curr Opin Infect Dis       Date:  2009-10       Impact factor: 4.915

Review 2.  Genetic susceptibility to invasive Salmonella disease.

Authors:  James J Gilchrist; Calman A MacLennan; Adrian V S Hill
Journal:  Nat Rev Immunol       Date:  2015-07       Impact factor: 53.106

Review 3.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

Review 4.  [Genetic susceptibility to infections].

Authors:  S J Ott; S Schreiber
Journal:  Internist (Berl)       Date:  2011-09       Impact factor: 0.743

5.  Typhoid Fever Complicated by Hemophagocytic Lymphohistiocytosis and Rhabdomyolysis.

Authors:  Lemuel R Non; Rupa Patel; Amir Esmaeeli; Vladimir Despotovic
Journal:  Am J Trop Med Hyg       Date:  2015-08-31       Impact factor: 2.345

Review 6.  Human Genetic Variation Influences Enteric Fever Progression.

Authors:  Pei Yee Ma; Jing En Tan; Edd Wyn Hee; Dylan Wang Xi Yong; Yi Shuan Heng; Wei Xiang Low; Xun Hui Wu; Christy Cletus; Dinesh Kumar Chellappan; Kyan Aung; Chean Yeah Yong; Yun Khoon Liew
Journal:  Cells       Date:  2021-02-06       Impact factor: 6.600

7.  The Hd, Hj, and Hz66 flagella variants of Salmonella enterica serovar Typhi modify host responses and cellular interactions.

Authors:  Fernanda Schreiber; Sally Kay; Gad Frankel; Simon Clare; David Goulding; Esther van de Vosse; Jaap T van Dissel; Richard Strugnell; Guy Thwaites; Robert A Kingsley; Gordon Dougan; Stephen Baker
Journal:  Sci Rep       Date:  2015-01-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.